Tapewire

Nasdaq · USD

AYTU

AYTU BIOPHARMA, INC

Export transactions ↓
Tapewire entity
7560
SEC CIK
0001385818
Parsed reports
150

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
November 02, 2016 Filed Nov 4, 2016 20:57 UTC
Disbrow JarrettDirector · Chief Operating Officer
PurchaseCommon Stock 166,666 $1.50 $249,999.00
Disclosure

SEC source: 0001638599-16-001507 · doc4_4276.xml · nonDerivative · entry 1

Disbrow Jarrett · CIK 0001640724 · Director · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 413,504

F1 · price: The shares of stock and warrants were purchased at a purchase price per unit of $1.50.

F2 · balance_after: Of these shares, 165,000 are restricted shares that vest on July 7, 2026, subject to earlier vesting in certain situations.

Read SEC document
November 02, 2016 Filed Nov 4, 2016 20:57 UTC
Disbrow Joshua R.Director · Chief Executive Officer
PurchaseWarrant to Purchase Common Stock · Derivative 166,666 Not disclosed Strike: $1.86 Not disclosed
Disclosure

SEC source: 0001638599-16-001506 · doc4_4275.xml · derivative · entry 2

Disbrow Joshua R. · CIK 0001566240 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 166,666

Underlying: Common Stock · 166,666 shares

Expires 2021-11-02

F1 · price: The shares of stock and warrants were purchased at a purchase price per unit of $1.50.

Read SEC document
November 02, 2016 Filed Nov 4, 2016 20:57 UTC
Disbrow Joshua R.Director · Chief Executive Officer
PurchaseCommon Stock 166,666 $1.50 $249,999.00
Disclosure

SEC source: 0001638599-16-001506 · doc4_4275.xml · nonDerivative · entry 1

Disbrow Joshua R. · CIK 0001566240 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 442,694

F1 · price: The shares of stock and warrants were purchased at a purchase price per unit of $1.50.

F2 · balance_after: Of these shares, 190,000 are restricted shares that vest on July 7, 2026, subject to earlier vesting in certain situations.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.